Clinical Trial Update: A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial for TAK-411 in adults with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyradiculoneuropathy

Drugs mentioned

• TAK-411

Snippet

Sponsor: Takeda | Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Phase 2 | Status: RECRUITING